CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

December 30, 2024

Period of Report

December 29, 2024

Accession Number

0002007191-24-000008